Melanoma, a cancer originated from melanocytes, frequently presents mutations in the MAPK pathway, mainly in BRAF and NRAS proteins, at incidences up to 52% and 28%, respectively, according to The Cancer Genome Atlas Network [3]. This evidence concerns the gene BRAF and melanoma.